Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EF5T
|
|||
| Drug Name |
PMID25656651-Compound-10
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
IRM LLC DING, Qiang SIM, Tae-bo ZHANG, Guobao ADRIAN, Francisco GRAY, Nathanael, S
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H17F3N4O3
|
|||
| Canonical SMILES |
C1=CC(=CC(=C1)C(=O)NCCO)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F
|
|||
| InChI |
1S/C20H17F3N4O3/c21-20(22,23)30-16-6-4-15(5-7-16)27-18-11-17(25-12-26-18)13-2-1-3-14(10-13)19(29)24-8-9-28/h1-7,10-12,28H,8-9H2,(H,24,29)(H,25,26,27)
|
|||
| InChIKey |
IIQUYGWWHIHOCF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 778277-15-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.